3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Rectal Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Esophageal Neoplasms
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colonic Neoplasms
1
Colonic Diseases
1
Interventions
tisagenlecleucel
2
fludarabine
2
blinatumomab
2
Cyclophosphamide
2
zanubrutinib
1
selinexor
1
revumenib
1
niraparib
1
nilotinib
1
ivosidenib
1
imetelstat
1
ibrutinib
1
entrectinib
1
dostarlimab
1
brexucabtagene autoleucel
1
avapritinib
1
asciminib
1
Standard of Care
1
Paclitaxel
1
Imatinib Mesylate
1
GRN163L peptide
1
Drug Therapy
1
Dexamethasone
1
Dasatinib
1
Carboplatin
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Recurrence
×
Irinotecan
×
Clear all
No trials found.